DONG-A ST CO., LTD.

Other languages Dong-A ST Co., Ltd.

Equities

A170900

KR7170900005

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
65,700 ^KRW	+0.61%		+0.15%	-4.92%

Mar. 18	Dong-A ST Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Jan. 24	GenEdit Inc. announced that it has received $24 million in funding from Korea Innovative Medicines Consortium, Dong-A ST Co., Ltd., Huons Co., Ltd.	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Dong-A ST Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 18
FDA Accepts for Review BLA for DMB-3115 of Dong-A ST, a Proposed Biosimilar to Stelara	Jan. 05
Dong-A ST Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14
Dong-A ST Sets Sight on European Market with Stelara Biosimilar Expansion	23-08-31
Dong-A ST Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
Dong-A ST Co., Ltd. announces an Equity Buyback for 38,373 shares.	23-07-26
Dong-A ST Co., Ltd. authorizes a Buyback Plan.	23-07-25
EMA Accepts MAA for DMB-3115 of Dong-A ST, a Stelara Biosimilar	23-07-17
Dong-A ST Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
Dong-A ST Co., Ltd. announces an Equity Buyback for 45,872 shares.	23-04-26
Dong-A ST Co., Ltd. authorizes a Buyback Plan.	23-04-25
Dong-A ST Co., Ltd. announces an Equity Buyback for 40,519 shares.	23-01-25
Dong-A ST Co., Ltd. authorizes a Buyback Plan.	23-01-25
Dong-A ST Co., Ltd. Demonstrates Therapeutic Equivalence Between DMB-3115 and Stelara in Global Phase III	23-01-17
Dong-A ST Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14
Dong-A ST Co., Ltd. announces an Equity Buyback for 50,301 shares.	22-10-26
Dong-A ST Co., Ltd. authorizes a Buyback Plan.	22-10-25
NeuroBo Pharmaceuticals, Inc. and Dong-A ST Co. Ltd. Announce Strategic Collaboration to License and Develop Portfolio of Dong-A's Cardio-Metabolic Therapies	22-09-15
Dong-A ST Co., Ltd. and Beactica Therapeutics AB Mutually Agree to Conclude Oncology Collaboration	22-09-06

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

More Top / Flop

Rankings

More Top / Flop

Currency / Forex

Commodities

Cryptocurrencies

Cryptocurrencies

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW